Azulix SM IR 50/2/500 mg Tablet - Strip of 10

• Azulix SM IR 50/2/500 mg Tablet provides comprehensive control over blood sugar levels.
• This medication effectively addresses the three main defects in Type 2 Diabetes: liver overproduction of glucose, insulin resistance, and pancreatic beta-cell dysfunction.
• It offers superior efficacy by achieving greater reductions in HbA1c compared to dual therapy alone.
• The combination of three medications into one tablet simplifies dosing and improves patient adherence.
• Azulix SM IR 50/2/500 mg Tablet promotes better sugar management with a lower risk of hypoglycemia due to its glucose-dependent mechanism.
• This therapy is particularly beneficial for patients who have not achieved adequate control with conventional two-drug regimens.
• Azulix SM IR 50/2/500 mg Tablet helps prevent complications associated with diabetes by maintaining optimal blood sugar levels.
• It is suitable for adults diagnosed with Type 2 Diabetes Mellitus who require intensive metabolic control.

Azulix SM IR 50/2/500 mg Tablet employs a combination of three pharmacological mechanisms to achieve effective glycemic control.

• Metformin decreases hepatic glucose production and improves insulin sensitivity in peripheral tissues, reducing systemic insulin resistance.
• Glimepiride stimulates insulin secretion from pancreatic beta-cells through K-ATP channel blockade, leading to immediate insulin release.
• Sitagliptin inhibits the DPP-4 enzyme, preserving incretin hormones that amplify insulin release and suppress glucagon production when blood glucose levels are high.
• This multi-faceted approach allows Azulix SM IR 50/2/500 mg Tablet to effectively manage blood sugar levels while minimizing the risk of hypoglycemia.
• The combination therapy simplifies treatment regimens for patients, enhancing adherence and overall management of Type 2 Diabetes.

• Azulix SM IR 50/2/500 mg Tablet should be taken orally as prescribed by your healthcare provider.
• It is recommended to take the tablet with food, preferably during the first major meal of the day to minimize gastrointestinal side effects.
• The tablet must be swallowed whole with a glass of water; do not crush or chew it.
• Regular monitoring of blood sugar levels is essential while using Azulix SM IR 50/2/500 mg Tablet.
• The standard dosage is one tablet daily; however, your doctor may adjust this based on your individual response and blood glucose targets.
• Be aware of the risk of hypoglycemia; carry a source of fast-acting sugar for emergencies.
• Consult your physician if you experience any unusual symptoms or if your blood sugar remains uncontrolled.
• Do not stop taking Azulix SM IR 50/2/500 mg Tablet without consulting your healthcare provider.

• Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins to support blood sugar management while on Azulix SM IR 50/2/500 mg Tablet.
• Avoid skipping meals to reduce the risk of hypoglycemia associated with Glimepiride; eat regular meals at consistent times each day.
• Engage in regular physical activity tailored to your ability; consult your doctor before starting any new exercise program.
• Monitor blood sugar levels regularly to track your response to Azulix SM IR 50/2/500 mg Tablet and make necessary adjustments with your healthcare provider.
• Avoid excessive alcohol consumption as it can interfere with blood sugar control and increase the risk of serious side effects from this medication.
• Stay hydrated and maintain proper fluid intake, especially during hot weather or when exercising to prevent dehydration.
• Practice good foot care by inspecting feet regularly for any injuries or sores; report any concerns to your healthcare provider promptly.

• Common side effects associated with Azulix SM IR 50/2/500 mg Tablet include gastrointestinal distress such as nausea, vomiting, diarrhea, and abdominal pain.
• Headaches may occur as a common side effect of this medication.
• Hypoglycemia is a significant risk due to the Glimepiride component; symptoms include sweating, shakiness, confusion, and rapid heartbeat.
• Upper respiratory tract infections and nasopharyngitis have been reported as side effects linked to Sitagliptin.
• Serious side effects requiring immediate medical attention include Lactic Acidosis characterized by unusual muscle pain, severe fatigue, difficulty breathing, stomach pain, dizziness, and cold sensations.
• Pancreatitis may present as severe abdominal pain radiating to the back; report this immediately to your doctor.
• Allergic reactions such as rash or swelling of the face and throat may occur; seek medical help if these symptoms arise.
• Severe hypoglycemia necessitates immediate treatment with sugar intake and medical assistance if symptoms persist.

• Azulix SM IR 50/2/500 mg Tablet should not be used in patients with severe renal impairment due to the risk of Metformin accumulation and Lactic Acidosis.
• Caution is advised in individuals with a history of pancreatitis due to the Sitagliptin component.
• Patients should avoid alcohol consumption while taking this medication as it increases the risk of hypoglycemia and Lactic Acidosis.
• Pregnant or breastfeeding women should consult their healthcare provider before using Azulix SM IR 50/2/500 mg Tablet.
• Regular monitoring of kidney function is essential during treatment with this medication.
• If experiencing symptoms of Lactic Acidosis or pancreatitis, seek immediate medical attention.
• Patients should inform their doctor about all medications they are taking to avoid potential drug interactions.
• Consult your healthcare provider before undergoing any surgical procedures or imaging studies involving iodinated contrast dye while on this medication.

• Store in a cool, dry place below 30°C
• Keep out of reach of children
• Protect from moisture and direct sunlight
• Dispose of unused or expired medication as directed by pharmacy or local waste disposal authorities